Concepedia

Katrina McCarten

KM

Statistics

Publications

4

Citations

207

H-Index

4

Active since

2018

Affiliations

AstraZeneca (United Kingdom)(Current)

Wellcome Sanger Institute

The Netherlands Cancer Institute

Candiolo Cancer Institute

Katrina McCarten is an author at AstraZeneca (United Kingdom) specializing in oncology, molecular oncology, and crispr-cas systems.

Publications per year

2018–2024

4

Publications

4

An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein

Pooran Singh Dewari, Benjamin Southgate, Katrina McCarten et al. · eLife · 2018 · 66 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Base editing screens define the genetic landscape of cancer drug resistance mechanisms

Matthew A. Coelho, Magdalena E Strauß, Alex Watterson et al. · Nature Genetics · 2024 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells

Gabriele Picco, Yanhua Rao, Angham Al Saedi et al. · Cancer Discovery · 2024 · 51 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations

Azadeh C. Bashi, Elizabeth A. Coker, Krishna C. Bulusu et al. · Cancer Discovery · 2024 · 37 citations · Full text

Medicine, Oncology, Pharmacology +10

1–4 of 4